4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-024129
Director & COO bought 15,100 shares at an average $0.89 ($13,514)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEE WILLIS C Director & COO | 2022-04-04 | Purchase | +3,200 | $0.98 | $3,136 | 238,194 | I |
| LEE WILLIS C Director & COO | 2022-04-06 | Purchase | +1,400 | $0.95 | $1,330 | 239,594 | I |
| LEE WILLIS C Director & COO | 2022-04-08 | Purchase | +1,600 | $0.76 | $1,216 | 241,194 | I |
| LEE WILLIS C Director & COO | 2022-04-11 | Purchase | +8,900 | $0.88 | $7,832 | 278,774 | D |
| Open-market purchases · 15,100 sh · avg $0.89 · $13,514 | |||||||
Loading xslF345X03/doc4.xml…